技術(shù)外包服務(wù):

★指狀蛋白RET抗體品牌 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

實驗流程：

指狀蛋白RET抗體品牌 英文名稱  Anti-RET/C ret

中文名稱  指狀蛋白RET抗體品牌 

別    名 C ret; CDHF 12; CDHF12; ELKS Fusion gene; HSCR 1; Hydroxyaryl protein kinase; MTC 1; Multiple endocrine neoplasia and medullary thyroid carcinoma 1; Oncogene RET; Proto oncogene tyrosine protein kinase receptor ret; RET ELE1; Ret Proto oncogene; RET transforming sequence; RET51; RET_HUMAN.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Rabbit

產(chǎn)品類型   一抗  

研究領(lǐng)域     細(xì)胞生物 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 生長因子和激素 激酶和磷酸酶 細(xì)胞膜受體

蛋白分子量  predicted molecular weight: 122kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human RET

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

指狀蛋白RET抗體品牌 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:1000-5000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed. [provided by RefSeq].

Function : Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Act as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration.

Subunit : Phosphorylated form interacts with the PBT domain of DOK2, DOK4 and DOK5. The phosphorylated form interacts with PLCG1 and GRB7 (By similarity). Interacts (not phosphorylated) with CC PTK2/FAK1 (via FERM domain). Extracellular cell-membrane anchored RET cadherin fragments form complex in neurons with reduced trophic status, preferentially at the contact sites between somas. Interacts with AIP in the pituitary gland; this interaction prevents the formation of the AIP-survivin complex. Binds to ARTN.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Endosome membrane; Single-pass type I membrane protein.

Post-translational modifications : Autophosphorylated on C-terminal tyrosine residues upon ligand stimulation. Dephosphorylated by PTPRJ on Tyr-905, Tyr-1015 and Tyr-1062.

Proteolytically cleaved by caspase-3. The soluble RET kinase fragment is able to induce cell death. The extracellular cell-membrane anchored RET cadherin fragment accelerates cell adhesion in sympathetic neurons.

DISEASE : Defects in RET may be a cause of colorectal cancer (CRC) [MIM:114500].

Defects in RET are a cause of Hirschsprung disease type 1 (HSCR1) [MIM:142623]. HSCR1 is a disorder of neural crest development characterized by the absence of intramural ganglion cells in the myenteric and submucosal plexuses of the gastrointestinal tract, often resulting in intestinal obstruction. Total colonic aganglionosis and total intestinal Hirschsprung disease also occur. Occasionally, MEN2A or FMTC occur in association with HSCR1.

Defects in RET are the cause of medullary thyroid carcinoma (MTC) [MIM:155240]. MTC is a rare tumor derived from the C cells of the thyroid. Three hereditary forms are known, that are transmitted in an autosomal dominant fashion: (a) multiple neoplasia type 2A (MEN2A), (b) multiple neoplasia type IIB (MEN2B) and (c) familial MTC (FMTC), which occurs in 25-30% of MTC cases and where MTC is the only clinical manifestation.

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family.

Contains 1 cadherin domain.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P07949.3

RET指狀蛋白屬于一個較大的B-盒環(huán)指蛋白家族，RET與酪氨酸激酶融合后就變?yōu)榘┗?

全、新、優(yōu)、品、好四大特點：

指狀蛋白RET抗體品牌 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

ITF(Human Intestinal trefoil factor) ELISA Kit 人腸三葉因子Multi-class antibodies規(guī)格： 48T

Anti-HCV-NS1 病毒-NS1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh MIG7 富含半胱氨酸蛋白質(zhì)MIG7抗體 規(guī)格 0.2ml

sPL-A2(Human soluble Phospholipase A2) ELISA Kit 人可溶性磷脂酶A2 96T

RIM2 英文名稱： 神經(jīng)元突觸膜胞外分泌調(diào)節(jié)蛋白2抗體 0.2ml

CGBP 英文名稱： CpG結(jié)合蛋白抗體 0.1ml

Anti-HCV-NS1 病毒-NS1抗體Multi-class antibodies規(guī)格： 0.1ml

Anti-LYVE-1/FITC 熒光素標(biāo)記淋巴管內(nèi)皮透明質(zhì)酸受體抗體Multi-class antibodies規(guī)格： 0.2ml

Anti-TBX2/T-box2/FITC 熒光素標(biāo)記新型基因抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh ADAR1 (N-terminus) 雙鏈RNA腺苷酸脫氨基酶抗體(N端) 規(guī)格 0.2ml

Rabbit Anti-chicken IgM/PE-CY5 PE-CY5標(biāo)記的兔抗雞IgM 0.1ml

G alpha gust 英文名稱： Gα gust抗體 0.2ml

Rhesus antibody Rh Rabbit Anti-chicken IgG/Cy3 Cy3標(biāo)記的兔抗雞IgG 規(guī)格 0.1ml

Anti-TBX2/T-box2/FITC 熒光素標(biāo)記新型基因抗體IgGMulti-class antibodies規(guī)格： 0.2ml

TGF Beta2(Human transforming growth factors Beta2) ELISA Kit 人轉(zhuǎn)化生長因子β2Multi-class antibodies規(guī)格： 48T

Anti-FSP/Spastin 纖維母細(xì)胞表面蛋白抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Mouse Anti-human IgM/AP 堿性磷酸酶(AP)標(biāo)記的小鼠抗人IgM 規(guī)格 0.1ml

IRAP(Human ICE protease-activating factor) ELISA Kit 人ICE蛋白酶激活因子 96T

SLITRK5 英文名稱： 神經(jīng)突觸相關(guān)蛋白SLITRK5抗體 0.2ml

CSMD2 英文名稱： CSMD2蛋白抗體 0.2ml

Anti-FSP/Spastin 纖維母細(xì)胞表面蛋白抗體Multi-class antibodies規(guī)格： 0.2ml

液體連四鹽培養(yǎng)基250g用于沙門氏菌選擇性增菌培養(yǎng)。

ECC顯色培養(yǎng)基B 25000mL/瓶 incubation media ECC顯色培養(yǎng)基B 25000mL/瓶

胰蛋白胨大豆肉湯培養(yǎng)基 250g 可廣泛應(yīng)用于細(xì)菌的培養(yǎng)，特別用于消毒劑消毒效果的測試、金黃色葡萄球菌的非選擇性增菌培養(yǎng)及蠟...

瓊脂培養(yǎng)基LAgarmediumL用于沙門氏菌的選擇性分離培養(yǎng)

M17Broth

土霉素麥芽提取物瓊脂培養(yǎng)基250g

氯化鎂孔雀綠肉湯(MM/RV/R10) 250(g) incubation media 氯化鎂孔雀綠肉湯(MM/RV/R10) 250(g)

高氏合成一號瓊脂培養(yǎng)基 GAUZEˊs Medium  250克 培養(yǎng)

緩沖李氏菌增菌肉湯基礎(chǔ)添加劑支每支加入225ml緩沖李氏菌增菌肉湯基礎(chǔ)中incubationmedia緩沖李氏菌增菌肉湯基礎(chǔ)添加劑支每支加入225ml緩沖李氏菌增菌肉湯基礎(chǔ)中

改良Camp-BAP氏瓊脂基礎(chǔ) 250g 用于彎曲桿菌選擇性分離培養(yǎng)(GB標(biāo)準(zhǔn))

指狀蛋白RET抗體品牌 葡萄糖銨培養(yǎng)基  規(guī)格：  100g  用途：  用于鑒別細(xì)菌利用*作為氮源并分解葡萄糖的試驗(GB/T4789.28－2003 中3.8，GB/T4789.5－20...

志賀氏增菌肉湯  規(guī)格：  250g  用途：  用于志賀氏菌的選擇性增菌培養(yǎng)。（GB4789.5-2010）

GN增菌液  規(guī)格：  250g  用途：  用于革蘭氏陰性菌的選擇性培養(yǎng)，特別是志賀氏菌和沙門氏菌的增菌培養(yǎng)(GB/T4789.28－2003 中4.17，...

乳糖肉湯  規(guī)格：  250g  用途：  用于沙門氏菌前增菌培養(yǎng)。（美國FDA charpter 4）